LINDSEY PITTILLO: Open Payments
NPI 1003497819 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 45 payments from 26 companies in 2025. Trend: 2023 $302 · 2024 $681 · 2025 $1,594
Food & beverage: $1,594
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 5 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $151 |
| ABBVIE INC. | 3 | $149 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| Merck Sharp & Dohme LLC | 1 | $115 |
| Regeneron Healthcare Solutions, Inc. | 2 | $110 |
| Daiichi Sankyo Inc. | 1 | $93 |
| Novocure Inc. | 1 | $77 |
| Caris MPI, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
Products named: Orserdu, Nubeqa, RYBREVANT, Enhertu, KEYTRUDA, LIBTAYO, Optune Lua (NovoTTF-200T), MI CANCER SEEK.
Industry payments across TX — which companies pay providers there.
